{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:51Z","timestamp":1707524751584},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.7759\/cureus.33184","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T18:28:27Z","timestamp":1672511307000},"source":"Crossref","is-referenced-by-count":0,"title":["Insurance Coverage of Dermabrasion and Chemical Peel Procedures: A Critical Analysis of 58 American Insurance Companies"],"prefix":"10.7759","author":[{"given":"Michael","family":"Ha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily R","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aasheen","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Ejimogu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne  M","family":"Rasko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.09.012","article-title":"Chemical peels","volume":"26","author":"Landau M","year":"2008","unstructured":"Landau M. Chemical peels. Clin Dermatol. 2008, 26:200-8. 10.1016\/j.clindermatol.2007.09.012","journal-title":"Clin Dermatol"},{"key":"ref2","unstructured":"Dermabrasion. (2018). Accessed. June 5. (2022). https:\/\/emedicine.medscape.com\/article\/1297069-overview."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07692.x","article-title":"Guidelines for the management of actinic keratoses","volume":"156","author":"de Berker D","year":"2007","unstructured":"de Berker D, McGregor JM, Hughes BR. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007, 156:222-30. 10.1111\/j.1365-2133.2006.07692.x","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2006.32228.x","article-title":"Frequency and cost of actinic keratosis treatment","volume":"32","author":"Warino L","year":"2006","unstructured":"Warino L, Tusa M, Camacho F, Teuschler H, Fleischer AB Jr, Feldman SR. Frequency and cost of actinic keratosis treatment. Dermatol Surg. 2006, 32:1045-9. 10.1111\/j.1524-4725.2006.32228.x","journal-title":"Dermatol Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-021-03381-3","article-title":"Dermabrasion combined with photodynamic therapy: a new option for the treatment of non-melanoma skin cancer","volume":"37","author":"Yu N","year":"2022","unstructured":"Yu N, Luo X, Wei T, et al.. Dermabrasion combined with photodynamic therapy: a new option for the treatment of non-melanoma skin cancer. Lasers Med Sci. 2022, 37:1255-63. 10.1007\/s10103-021-03381-3","journal-title":"Lasers Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S31930","article-title":"Optimal treatment of actinic keratoses","volume":"8","author":"Uhlenhake EE","year":"2013","unstructured":"Uhlenhake EE. Optimal treatment of actinic keratoses. Clin Interv Aging. 2013, 8:29-35. 10.2147\/CIA.S31930","journal-title":"Clin Interv Aging"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(86)70083-2","article-title":"Dermabrasion of the scalp as a treatment for actinic damage","volume":"14","author":"Winton GB","year":"1986","unstructured":"Winton GB, Salasche SJ. Dermabrasion of the scalp as a treatment for actinic damage. J Am Acad Dermatol. 1986, 14:661-68. 10.1016\/s0190-9622(86)70083-2","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1996.tb00565.x","article-title":"Dermabrasion for prophylaxis and treatment of actinic keratoses","volume":"22","author":"Coleman WP","year":"1996","unstructured":"Coleman WP, Yarborough JM, Mandy SH. Dermabrasion for prophylaxis and treatment of actinic keratoses. Dermatol Surg. 1996, 22:17-21. 10.1111\/j.1524-4725.1996.tb00565.x","journal-title":"Dermatol Surg"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1995.01690140060009","article-title":"A comparison of the efficacy and safety of Jessner's solution and 35% trichloracetic acid vs. 5% fluorouracil in the treatment of widespread facial actinic keratoses","volume":"131","author":"Lawrence N","year":"1995","unstructured":"Lawrence N, Cox SE, Cockerell CJ, Freeman RG, Cruz PD Jr. A comparison of the efficacy and safety of Jessner's solution and 35% trichloracetic acid vs. 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol. 1995, 131:173-81.","journal-title":"Arch Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.8.976","article-title":"Facial resurfacing for nonmelanoma skin cancer prophylaxis","volume":"142","author":"Hantash BM","year":"2006","unstructured":"Hantash BM, Stewart DB, Cooper ZA, Rehmus WE, Koch RJ, Swetter SM. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol. 2006, 142:976-82. 10.1001\/archderm.142.8.976","journal-title":"Arch Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4236\/jcdsa.2013.33A2008","article-title":"Treatment of active acne vulgaris by chemical peeling using TCA 35%","volume":"3","author":"Sharquie KE","year":"2013","unstructured":"Sharquie KE, Noaimi AA, Al-Janabi EA. Treatment of active acne vulgaris by chemical peeling using TCA 35%. J Cosmet Dermatol Sci Appl. 2013, 3:32-35. 10.4236\/jcdsa.2013.33A2008","journal-title":"J Cosmet Dermatol Sci Appl"},{"key":"ref12","article-title":"Standard guidelines of care for acne surgery","volume":"74","author":"Khunger N","year":"2008","unstructured":"Khunger N. Standard guidelines of care for acne surgery. Indian J Dermatol Venereol Leprol. 2008, 74:28-36.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2011.00572.x","article-title":"A 10% glycolic acid containing oil-in-water emulsion improves mild acne: a randomized double-blind placebo-controlled trial","volume":"10","author":"Abels C","year":"2011","unstructured":"Abels C, Kaszuba A, Michalak I, Werdier D, Knie U, Kaszuba A. A 10% glycolic acid containing oil-in-water emulsion improves mild acne: a randomized double-blind placebo-controlled trial. J Cosmet Dermatol. 2011, 10:202-9. 10.1111\/j.1473-2165.2011.00572.x","journal-title":"J Cosmet Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.05.029","article-title":"Acne scarring: a review and current treatment modalities","volume":"59","author":"Rivera AE","year":"2008","unstructured":"Rivera AE. Acne scarring: a review and current treatment modalities. J Am Acad Dermatol. 2008, 59:659-76. 10.1016\/j.jaad.2008.05.029","journal-title":"J Am Acad Dermatol"},{"key":"ref15","article-title":"Atrophic acne scarring: a review of treatment options","volume":"8","author":"Hession MT","year":"2015","unstructured":"Hession MT, Graber EM. Atrophic acne scarring: a review of treatment options. J Clin Aesthet Dermatol. 2015, 8:50-8.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref16","article-title":"Effective treatments of atrophic acne scars","volume":"8","author":"Gozali MV","year":"2015","unstructured":"Gozali MV, Zhou B. Effective treatments of atrophic acne scars. J Clin Aesthet Dermatol. 2015, 8:33-40.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref17","unstructured":"How much does a chemical peel cost? Accessed. June 5. (2022). https:\/\/www.plasticsurgery.org\/cosmetic-procedures\/chemical-peel\/cost.."},{"key":"ref18","unstructured":"How much does dermabrasion cost? Accessed. June 5. (2022). https:\/\/www.plasticsurgery.org\/cosmetic-procedures\/dermabrasion\/cost.."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2022.03.008","article-title":"A review of American insurance coverage and criteria for conservative management of lymphedema","volume":"10","author":"Finkelstein ER","year":"2022","unstructured":"Finkelstein ER, Ha M, Hanwright P, et al.. A review of American insurance coverage and criteria for conservative management of lymphedema. J Vasc Surg Venous Lymphat Disord. 2022, 10:929-36. 10.1016\/j.jvsv.2022.03.008","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2022.07.007","article-title":"A critical analysis of American insurance coverage for imaging and surgical treatment of lymphedema","volume":"10","author":"Finkelstein ER","year":"2022","unstructured":"Finkelstein ER, Ha M, Hanwright P, et al.. A critical analysis of American insurance coverage for imaging and surgical treatment of lymphedema. J Vasc Surg Venous Lymphat Disord. 2022, 10:1367-75. 10.1016\/j.jvsv.2022.07.007","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref21","unstructured":"Market Share and Enrollment of Largest Three Insurers - Individual Market. (2017). Accessed. February 28, 2021: https:\/\/www.kff.org\/private-insurance\/state-indicator\/market-share-and-enrollment-of-largest-three-insurers-individua...."},{"key":"ref22","unstructured":"Market share reports for the top 125 accident and health insurance groups and companies by state and countrywide. (2018). Accessed. February 28, 2021: https:\/\/www.naic.org\/prod_serv\/MSR-HB-18.pdf.."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.10.006","article-title":"Guidelines of care for the management of basal cell carcinoma","volume":"78","author":"Kim JY","year":"2018","unstructured":"Kim JY, Kozlow JH, Mittal B, Moyer J, Olencki T, Rodgers P. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol. 2018, 78:540-59. 10.1016\/j.jaad.2017.10.006","journal-title":"J Am Acad Dermatol"},{"key":"ref24","unstructured":"Skin Conditions by the Numbers. (2022). Accessed. June 1. (2022). https:\/\/www.aad.org\/media\/stats-numbers."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12763","article-title":"Combination chemical peels are more effective than single chemical peel in treatment of mild-to-moderate acne vulgaris: A split face comparative clinical trial","volume":"17","author":"Nofal E","year":"2018","unstructured":"Nofal E, Nofal A, Gharib K, Nasr M, Abdelshafy A, Elsaid E. Combination chemical peels are more effective than single chemical peel in treatment of mild-to-moderate acne vulgaris: A split face comparative clinical trial. J Cosmet Dermatol. 2018, 17:802-10. 10.1111\/jocd.12763","journal-title":"J Cosmet Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2006.06110.x","article-title":"Acne vulgaris--psychosomatic aspects","volume":"4","author":"Niemeier V","year":"2006","unstructured":"Niemeier V, Kupfer J, Gieler U. Acne vulgaris--psychosomatic aspects. J Dtsch Dermatol Ges. 2006, 4:1027-36. 10.1111\/j.1610-0387.2006.06110.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref27","unstructured":"Young people\u2019s mental health is finally getting the attention it needs. (2021). Accessed. September 1. (2022). https:\/\/www.nature.com\/articles\/d41586-021-02690-5."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.6144","article-title":"The role of the physician in patient perceptions of barriers to primary adherence with acne medications","volume":"154","author":"Ryskina KL","year":"2018","unstructured":"Ryskina KL, Goldberg E, Lott B, Hermann D, Barbieri JS, Lipoff JB. The role of the physician in patient perceptions of barriers to primary adherence with acne medications. JAMA Dermatol. 2018, 154:456-9. 10.1001\/jamadermatol.2017.6144","journal-title":"JAMA Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.5254","article-title":"Frequency of primary nonadherence to acne treatment","volume":"151","author":"Anderson KL","year":"2015","unstructured":"Anderson KL, Dothard EH, Huang KE, Feldman SR. Frequency of primary nonadherence to acne treatment. JAMA Dermatol. 2015, 151:623-6. 10.1001\/jamadermatol.2014.5254","journal-title":"JAMA Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1087-0024.2003.09104.x","article-title":"Report on \"Burden of Skin Disease\" Workshop. NIAMS, September 2002","volume":"9","author":"Qureshi AA","year":"2004","unstructured":"Qureshi AA, Freedberg I, Goldsmith L, Moshell A. Report on \"Burden of Skin Disease\" Workshop. NIAMS, September 2002. J Investig Dermatol Symp Proc. 2004, 9:111-9. 10.1046\/j.1087-0024.2003.09104.x","journal-title":"J Investig Dermatol Symp Proc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/129912-insurance-coverage-of-dermabrasion-and-chemical-peel-procedures-a-critical-analysis-of-58-american-insurance-companies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:30Z","timestamp":1707508050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/129912-insurance-coverage-of-dermabrasion-and-chemical-peel-procedures-a-critical-analysis-of-58-american-insurance-companies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,31]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.33184","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,31]]}}}